Provided by Tiger Trade Technology Pte. Ltd.

NewMarket

604.95
-3.5250-0.58%
Volume:83.93K
Turnover:50.85M
Market Cap:5.68B
PE:13.61
High:611.50
Open:608.42
Low:596.37
Close:608.47
52wk High:875.97
52wk Low:510.07
Shares:9.40M
Float Shares:7.78M
Volume Ratio:0.56
T/O Rate:1.08%
Dividend:11.25
Dividend Rate:1.86%
EPS(TTM):44.44
EPS(LYR):44.44
ROE:25.85%
ROA:11.27%
PB:3.20
PE(LYR):13.61

Loading ...

Is Neuren’s 5 Percent Share Buyback Altering The Investment Case For Neuren Pharmaceuticals (ASX:NEU)?

Simply Wall St.
·
3 hours ago

NewMarket names Susan M. Ridlehoover principal accounting officer

Reuters
·
Yesterday

Assessing NewMarket (NEU) Valuation As Shares Trade Near Half Of DCF Fair Value Estimate

Simply Wall St.
·
Feb 17

NewMarket (NEU) Margin Decline Challenges Long Term Earnings Growth Narrative

Simply Wall St.
·
Feb 13

Neuren Pharmaceuticals (ASX:NEU) Valuation Check As New Share Buy-Back Targets 5% Of Share Capital

Simply Wall St.
·
Feb 13

NewMarket Corp FY2025 interest and financing expenses drop to USD 40 million, down 29%

Reuters
·
Feb 13

NewMarket Corp. Down Nearly 13%, on Pace for Largest Percent Decrease Since February 2012 -- Data Talk

Dow Jones
·
Feb 13

NewMarket Q4 Earnings, Sales Fall

MT Newswires Live
·
Feb 12

NewMarket posts FY 2025 net income of USD 419 million

Reuters
·
Feb 12

Earnings Flash (NEU) NewMarket Posts Q4 EPS of $8.65

MT Newswires Live
·
Feb 12

NewMarket Q4 revenue declines

Reuters
·
Feb 12

NewMarket Q4 EPS $8.65 Down From $11.56 YoY, Sales $635.403M Down From $654.647M YoY

Benzinga
·
Feb 12

BRIEF-NewMarket Q4 Net Income USD 81.285 Million

Reuters
·
Feb 12

NewMarket Q4 Segment Operating Profit USD 111.574 Million

THOMSON REUTERS
·
Feb 12

NewMarket Q4 Sales USD 635.403 Million

THOMSON REUTERS
·
Feb 12

NewMarket Q4 EPS USD 8.65

THOMSON REUTERS
·
Feb 12

Slammed 30% Neuren Pharmaceuticals Limited (ASX:NEU) Screens Well Here But There Might Be A Catch

Simply Wall St.
·
Feb 06

Neuren Pharmaceuticals (ASX:NEU) Is Down 16.1% After EMA Setback on Trofinetide Approval Prospects

Simply Wall St.
·
Feb 04

Earning Preview: NewMarket revenue is expected to be stable, and institutional views tilt neutral to cautious

Earnings Agent
·
Feb 04

Neuren Pharmaceuticals (ASX:NEU) Valuation Check After DAYBUE Growth Outlook And Pipeline Progress

Simply Wall St.
·
Jan 16